60 Degrees Pharmaceuticals Inc. SXTP
1.17
0.02
1.74%
as of 25 Sep
- Market cap
- $4.1M
- P/E
- 0.0×
Follow SXTP
Insider Buys
alert about insiders buying in the last 12 month
| Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
25.28 | 25.28 | 25.28 | 16.08 | 4.32 | 0.97 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(35.47) | (35.47) | (35.47) | (64.03) | (1.80) | (0.80) |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
28.01 | 28.01 | 28.01 | 8.24 | (0.43) | (0.88) |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.17 |
EV/Operating CF |
(11.21) | (11.21) | (11.21) | (0.46) | 0.05 | 0.18 |
EV/FCF |
(10.76) | (10.76) | (10.76) | (0.45) | 0.05 | 0.18 |
Quick Ratio |
0.73 | 0.41 | 0.01 | 0.84 | 2.34 | 1.77 |
Current Ratio |
1.70 | 1.85 | 0.05 | 2.55 | 3.25 | 2.66 |
Net Debt/EBITDA |
(48.69) | (41.47) | (10.11) | 0.64 | 0.56 | 0.37 |
Debt/Assets |
736.50% | 1,340.47% | 415.23% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
(1.10) | (1.03) | (0.22) | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 3.18 | 0.38 | 0.06 | 0.10 | 0.25 |
Operating CF/Net income |
0.06 | 0.15 | 0.16 | 1.21 | 0.71 | 0.93 |
Capex/Depreciation |
0.00 | (0.05) | (0.05) | (0.06) | (0.05) | (0.84) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | 23.85% | 29.23% | 25.78% | 148.93% | 124.83% | |
| 0.00% | (212.61%) | (459.49%) | (82.94%) | (117.36%) | (132.40%) | |
ROIC |
0.00% | (171.52%) | 0.00% | (121.31%) | (1,070.52%) | (771.42%) |
Return on Tangible Assets |
(280.12%) | (720.50%) | 27.11% | (84.34%) | (204.88%) | (223.25%) |
Average Days of Receivables |
123.04 | 8.41 | 32.84 | 332.90 | 260.74 | 132.00 |
Research and Development Expense of Revenue |
31.64% | 86.75% | 102.82% | 272.79% | 731.91% | 149.47% |
Selling, General and Administrative Expense of Revenue |
57.18% | 17.56% | 255.03% | 1,672.63% | 737.59% | 445.66% |
Intangible Assets out of Total Assets |
0.03 | 0.08 | 0.13 | 0.03 | 0.03 | 0.04 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 356.78% | 4.81% | 19.86% |
Graham Net Nets |
(2.21) | (2.21) | (2.21) | 1.04 | 1.22 | 2.14 |
Graham Number |
0.00 | 0.00 | 0.00 | 1,908.07 | 284.49 | 48.31 |
Earnings Yield |
(86.59%) | (86.59%) | (86.59%) | (213.45%) | (283.19%) | (553.22%) |
Free Cash Flow Yield |
(10.30%) | (10.30%) | (10.30%) | (114.22%) | (198.19%) | (519.60%) |
Revenue per Share |
0.44 | 1.10 | 51.64 | 15.37 | 5.98 | 2.10 |
Operating CF per Share |
(0.03) | (0.11) | (102.02) | (275.33) | (49.54) | (10.22) |
Capex per Share |
0.00 | (0.01) | (6.08) | (7.02) | (1.59) | (0.33) |
Free Cash Flow per Share |
(0.03) | (0.12) | (108.10) | (282.35) | (51.13) | (10.55) |
Cash per Share |
0.03 | 0.02 | 26.76 | 129.85 | 29.72 | 4.11 |
Shareholders Equity per Share |
(3.03) | (3.14) | (2,439.30) | 290.79 | 34.69 | 5.04 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(3.03) | (3.14) | (2,439.30) | 290.79 | 34.69 | 5.04 |
Free Cash Flow |
(0.17) | (0.68) | (1.07) | (4.66) | (5.83) | (7.07) |
Working Capital |
1.01 | 0.54 | (22.82) | 4.41 | 3.73 | 3.05 |
Capital Expenditures |
(0.07) | (0.04) | (0.06) | (0.12) | (0.18) | (0.22) |
Net Current Asset Value |
(18.23) | (18.37) | (24.35) | 4.26 | 3.58 | 2.91 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.16 |
Capex to Sales |
0.00 | 0.01 | 0.12 | 0.46 | 0.27 | 0.15 |
Net Profit Margin |
(118.99%) | (66.93%) | (1,209.25%) | (1,484.90%) | (1,166.46%) | (522.69%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||
Depreciation/Fixed assets |
0.38 | 13.83 | 58.39 | 31.69 | 24.30 | 1.05 |
Cash ROIC |
(12.78%) | (108.99%) | 5.58% | (66.29%) | (78.96%) | (115.75%) |
Accounts Receivable Turnover |
0.00 | 12.63 | 5.31 | 1.83 | 1.90 | 2.83 |
Accounts Payable Turnover |
0.00 | 0.87 | 0.64 | 0.75 | 0.51 | 0.63 |
Inventory Turnover |
0.00 | 0.98 | 0.72 | 0.96 | 0.85 | 1.42 |
Average Days of Payables |
714.94 | 252.59 | 640.44 | 389.30 | 955.75 | 681.39 |
Days of Inventory on Hand |
539.76 | 295.62 | 437.76 | 358.54 | 420.02 | 306.73 |
Average Receivables |
— | 0.50 | 0.10 | 0.14 | 0.36 | 0.50 |
Average Payables |
— | 0.98 | 0.67 | 0.63 | 0.76 | 1.23 |
Average Inventory |
— | 0.86 | 0.60 | 0.49 | 0.45 | 0.55 |
Average Assets |
— | 2.00 | 1.35 | 4.54 | 6.77 | 5.56 |
Average Common Equity |
— | (17.83) | (21.15) | (14.60) | (5.34) | (5.90) |
Columns are period end dates